H35.2
Other non-diabetic proliferative retinopathy
Clinical Classification Guidelines
Inclusion Terms
- Proliferative vitreo-retinopathy
- Thalassemia proliferative retinopathy
Excludes Type 1
- proliferative vitreo-retinopathy with retinal detachment (H33.4-)
Excludes Type 2
- proliferative sickle-cell retinopathy (H36.82-)
Medical Intelligence & Overview
Other non-diabetic proliferative retinopathy (ICD-10 code H35.2) is a condition involving abnormal growth of blood vessels in the retina, the light-sensitive layer at the back of the eye. Unlike diabetic retinopathy, which is caused by diabetes, this form of retinopathy occurs due to other underlying health issues or eye-related factors. This condition can lead to vision problems if not identified and managed appropriately. It encompasses various specific types of proliferative retinopathies, including proliferative vitreo-retinopathy and thalassemia proliferative retinopathy, which involve abnormal blood vessel growth and changes within the eye, particularly affecting the vitreous and retina.
Causes & Symptoms
Clinical Causes: Certain blood disorders such as thalassemia. Proliferative vitreo-retinopathy, often associated with other ocular conditions. Chronic retinal ischemia or lack of adequate blood flow to the retina. Previous eye injuries or surgeries leading to abnormal blood vessel growth. Genetic predispositions affecting retinal blood vessels. Other systemic or ocular conditions causing abnormal neovascularization in the retina.
Key Symptoms: Gradual loss of vision or blurred vision. Floaters or dark spots scattered across the field of vision. Sight disturbances like shadows or curtain-like effects. Potential sudden vision loss if bleeding occurs within the eye. No noticeable symptoms in early stages; detailed eye examination may be necessary for diagnosis.
Diagnostic & Treatment
Diagnosis Path: Diagnosis usually involves comprehensive eye examinations, including dilated fundoscopy to visualize the retina thoroughly. Additional imaging tests such as optical coherence tomography (OCT) and fluorescein angiography help assess the extent of abnormal blood vessel growth and any associated bleeding or retinal detachment. An eye specialist may also review the patient's medical history and look for underlying conditions like blood disorders that contribute to the retinopathy.
Treatment Protocols: Treatment options aim to slow or halt abnormal blood vessel growth and prevent vision loss. These include:
Clinical Advice & FAQs
Billing Guidance
Is H35.2 a billable ICD-10 code?
Yes, H35.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.2?
Clinical documentation must specify the nature of Other non-diabetic proliferative retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference